Actavis Group PTC Ehf and others (Respondents) v ICOS Corporation and another (Appellants)
[2019] UKSC 15
Citation 1
…ries (UK) Ltd v Eli Lilly and Co Ltd [2010] RPC 9, para 102 per Lord Neuberger of Abbotsbury MR; Eli Lilly and Co v Human Genome Sciences Inc [2011] UKSC 51; [2012] 1 All ER 1154; [2012] RPC 6, paras 83-87 per Lord Neuberger. 57. The general principle that the extent of the patent monopoly should correspond to an…
Evolva SA
[2017] APO 57
Citation 2
…le herbicides /AgrEvo T 0939/92. [35] AP-1 /John Hopkins University School of Medicine T 1329/04. [36] Human Genome Sciences Inc v Eli Lilly & Co [2011] UKSC 51; [2012] RPC 6. [37] Conor v Angiotech ibid .…
Actavis Group PTC EHF & Ors v ICOS Corporation & Anor
[2019] UKSC 15
Citation 3
…ratories (UK) Ltd v Eli Lilly and Co Ltd [2010] RPC 9, para 102 per Lord Neuberger of Abbotsbury MR; Eli Lilly and Co v Human Genome Sciences Inc [2011] UKSC 51; [2012] 1 All ER 1154; [2012] RPC 6, paras 83-87 per Lord Neuberger.…
Schutz (UK) Ltd v Werit (UK) Ltd (Rev 1)
[2013] UKSC 16
Citation 4
…ew – see, most recently, Human Genome Sciences Inc v Eli Lilly & Co [2011] UKSC 51, [2012] 1 All ER 1154, paras 84-87, and Case Xa ZR 130/07. The parties in this case have not referred to any relevant decision of the EPO, as we are here concerned with infringement. However, it is worth addressing four decisions o…